Schedule 13D ownership disclosure

VeraDermics, Inc.

Common Stock, $0.00001 par value per share · CUSIP: 922967104

Event date: 2026-02-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Longitude Capital Partners V, LLCReported CIK 0002018312

    Shares: 2,600,399 · Class: 7.0%

  • Longitude Venture Partners V, L.P.Reported CIK 0001935964

    Shares: 2,600,399 · Class: 7.0%

  • Longitude 103.8 East Partners, LLCReported CIK 0002094273

    Shares: 2,053,474 · Class: 5.5%

  • Longitude 103.8 East, L.P.Reported CIK 0002094269

    Shares: 2,053,474 · Class: 5.5%

  • Patrick G. EnrightReported CIK 0001253886

    Shares: 4,653,873 · Class: 12.5%

  • Juliet Tammenoms BakkerReported CIK 0001431159

    Shares: 4,653,873 · Class: 12.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-049157
Form type
SCHEDULE 13D
Filer
Longitude Capital Partners V, LLC
CIK
CIK 2018312
Filed
Feb 12, 2026
Reporting period
Feb 05, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub